Related Experiment Video
Updated: Aug 17, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important
Peter J Cowburn1, Harshna Patel, Rebecca R Pipes
1Mount Sinai Hospital, 600 University Avenue, Suite 1609, Toronto, Ontario, Canada, M5G 1X5.
Insights
Contrast nephropathy, a kidney complication, affects 14% of patients after cardiac resynchronization therapy (CRT). This under-recognized risk increases morbidity, mortality, and hospital stays, requiring greater patient and physician awareness.
Area of Science:
- Cardiology
- Nephrology
- Medical Complications
Background:
- Cardiac resynchronization therapy (CRT) is an advanced treatment for heart failure.
- CRT procedures are technically complex and carry inherent risks.
- Contrast nephropathy is a known complication of angiography but not previously described after CRT.
Purpose of the Study:
- To determine the incidence of contrast nephropathy in patients undergoing CRT.
- To identify risk factors and outcomes associated with contrast nephropathy post-CRT.
Main Methods:
- Retrospective chart review of patients who underwent CRT at a tertiary referral center.
- Contrast nephropathy defined as a ≥25% increase in serum creatinine within 48 hours of contrast administration.
Main Results:
- 14% (10 of 68 patients) developed contrast nephropathy.
- Pre-existing elevated creatinine (≥200 µmol/L) was associated with higher risk (43% vs. 7%).
- Contrast nephropathy led to significantly longer hospital stays (19 days vs. 4 days).
Conclusions:
- Contrast nephropathy is a frequent and under-recognized complication of CRT.
- This complication is associated with significant morbidity, mortality, and increased healthcare costs.
- Increased awareness among patients and physicians regarding this risk is crucial.
Objectives:
The aim of the study was to define the incidence of contrast nephropathy in patients undergoing cardiac resynchronization therapy (CRT).
Background:
CRT is a promising new treatment for advanced heart failure. It is a technically demanding procedure with a recognized failure/complication rate. Contrast nephropathy is a well-recognized complication of coronary angiography/intervention, but has not been described following CRT.
Methods:
We performed a retrospective chart review of patients who had undergone CRT at Mount Sinai Hospital, a tertiary referral center for heart failure management, to define the incidence of contrast nephropathy in patients undergoing CRT. Contrast nephropathy was defined as the occurrence of a 25% or greater increase in serum creatinine within 48 h after contrast administration.
Results:
Sixty-eight patients underwent a total of seventy-three procedures between October 1st 2000 and December 31st 2003. Ten patients (14%) developed contrast nephropathy. Three of these patients (4%) required hemofiltration and one died. Patients with creatinine > or = 200 micromol/l (2.26 mg/dl) were more likely to develop contrast nephropathy than those with creatinine < 200 micromol/l (6/14 patients [43%] v 4/59 patients [7%], p<0.01). The mean length of hospital stay post-procedure in patients developing contrast nephropathy was 19+/-18 (SD) days versus 4+/-5 days for those patients with stable renal function (p<0.01).
Conclusions:
Contrast nephropathy is a frequent, but under-recognized complication of CRT with important morbidity/mortality. The extended hospital stay associated with contrast nephropathy has important clinical and health care implications. Patients and physicians need to be aware of this potential risk.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy IV: Restrictive Cardiomyopathy
Continuous Renal Replacement Therapy
Cardiomyopathy II: Dilated Cardiomyopathy
Diabetic Nephropathy
Chronic Kidney Disease IV: Nursing Management
